Believe in What You See.

The tumor microenvironment is complex. Your research doesn’t have to be.

Introducing Bethyl’s IHC PathPlex™ Multiplex Antibody Panels. Quickly detect multiple antigens in a single tissue section to gain clear understanding of the microenvironment without compromising samples.

Believe in What You See.

The tumor microenvironment is complex. Your research doesn’t have to be.

Introducing Bethyl’s IHC PathPlex™ Multiplex Antibody Panels. Quickly detect multiple antigens in a single tissue section to gain clear understanding of the microenvironment without compromising samples.

Advantages of Multiplexing

With the advancement of immunotherapeutics, the urge to understand the tumor microenvironment has never been more pressing. Molecular histopathology has recently been shifting from single-marker immunohistochemistry towards multiplexed marker detection. Multiplex immunohistochemistry maximizes the amount of data acquired from an individual sample. Recent advances in multiplex immunohistochemistry and multispectral imaging facilitate accurate simultaneous analysis of multiple tissue markers. Clinically, understanding of the tumor microenvironment, and subsequent selection of appropriately-targeted therapies, can be augmented by profiling and localizing immune checkpoint proteins. The applications of multiplex immunohistochemistry are numerous, and span clinical, translational, and basic research applications.

Maximize limited samples

Visualize multiple targets within a single tissue

Preserve tissue architecture

Obtain spatial information and co-expression within the TME

Clear counterstaining with DAPI

Hematoxylin can be obscured by other targets with chromogenic staining

Detect low-level binding sites

Fluorophores have a wider dynamic range and larger linear range than chromogenic substrates

Measure intensity for each target

Fluorescence signals can be overlaid and seen as single or multi-channel

Want to Learn More About Multiplexing?

Read related content:

IHC PathPlex™

To serve your multiplex research needs, Bethyl introduces IHC PathPlex™ panels to profile the complex tumor microenvironment. Each antibody has been validated for IHC and utilized in a multiplex format by our own scientists via proprietary processes to ensure the highest quality. With over 45 years of experience, Bethyl is recognized as a leading antibody manufacturer trusted by researchers around the world.

Pick any of the three core panels and add one or more antibody of your liking from our immuno-oncology inventory.

IHC PathPlex™ Core Panels

T-Cell I/O Panel

CD3

CD8

PD-L1

Lymphocyte Panel

CD3

CD8

CD20

T, B & M Panel

CD3

CD20

CD68

Get our Multiplex IHC Poster

Multiplex immunohistochemistry (mIHC) enables the tracking of multiple markers within the tumor microenvironment. See the advantages of Multiplex IHC.

Get this Tumor Immune Microenvironment Supplement

The reviews and research in this supplement offer a snapshot of the latest advances in research into the roles and regulation of immune cells in cancer.

Get our Stars of the Show Poster

Get the full picture with trusted tumor immune response results from our in-house validated antibodies.

Get this Immune Checkpoints in Cancer Therapy Supplement

This collection showcases the current progress from genomic and proteomic approaches that are providing a view into the responses to checkpoint blockade therapies to mechanistic studies that are defining the biochemical pathways that mediate an active response or resistance.

Detection of human CD3 (yellow), CD8 (red), and CD20 (green) in FFPE tonsil by IHC-IF.
 

Read More

Rabbit anti-CD3e recombinant monoclonal [BL-298-5D12] (A700-016), rabbit anti-CD8a recombinant monoclonal [BLR044F] (A700-044), mouse anti-CD20 monoclonal [L26] (A500-017A). Secondary: HRP-conjugated goat anti-rabbit IgG (A120-501P) and HRP-conjugated goat anti-mouse IgG (A90-116P). Substrate: Opal™ 520, 620, and 690. Counterstain: DAPI (blue).

Detection of human CD8 (red), FoxP3 (green), and PD-L1 (orange) in FFPE breast carcinoma by IHC-IF.

Read More

Antibodies: CD8 (A700-044), FoxP3 (A700-034), and PD-L1 (A700-020). Substrate: Opal™ reagent. Counterstain: DAPI (blue).

Detection of human CD3 (teal), CD8 (green), CD68 (orange), CK (red), Ki67 (yellow) and PD-L1 (white) in FFPE HNSCC by IHC-IF.

Read More

Rabbit anti-CD3e recombinant monoclonal [BL-298-5D12] (A700-016), rabbit anti-CD8a recombinant monoclonal [BLR044F] (A700-044), mouse anti-CD68 monoclonal [KP-1] (A500-018A), mouse anti-cytokeratin monoclonal [AE1/AE3] (A500-019A), rabbit anti-Ki67 monoclonal [BLR021E] (A700-021) and rabbit anti-PD-L1 recombinant monoclonal [BLR020E] (A700-020). Secondary: HRP-conjugated goat anti-rabbit IgG (A120-501P) and HRP-conjugated goat anti-mouse IgG (A90-116P). Substrate: Opal™ 480, 520, 570, 620, 690 and 780. Counterstain: DAPI (blue).

Ready to Start Multiplexing?

We Make Every Antibody We Sell.

Bethyl is dedicated to delivering the highest standards of product and service quality. Recognizing that your research and time are valuable, we promise to stand behind our products. Every Bethyl product ships with a 100% guarantee; choose Bethyl antibodies with confidence.

Learn more about our validation process and our product guarantee.

Bethyl Laboratories, Inc. • P.O. Box 850 • Montgomery, TX 77356
1-800-338-9579 • Fax: 1-866-597-6105
© 2019 - Bethyl Laboratories, Inc. All rights reserved.